Global
Global Fin Swe Nor Den Ger Cze Svk Pol Hun USA
Log in
  • Logo
  • Products
  • About us
  • News
  • Contact
  • Careers
Search
Logo
  • COVID-19
    • COVID-19 tests
      • Biosynex Covid-19 Ag BSS Rapid Test
  • Point of care
    • QuikRead go
      • QuikRead go Instrument
      • QuikRead go easy CRP
      • QuikRead go CRP
      • QuikRead go CRP+Hb
      • QuikRead go wrCRP
      • QuikRead go wrCRP+Hb
      • QuikRead go HbA1c
      • QuikRead go Strep A
      • QuikRead go iFOBT
      • QuikRead go accessories
    • QuikRead
      • QuikRead 101 Instrument
      • QuikRead CRP
      • QuikRead FOB quantitative
      • QuikRead U-ALB
      • QuikRead 101 accessories
  • Microbiology
    • Uricult
    • Uricult Vet
    • Cultura M
  • Molecular Diagnostics
    • SIBA
  • Hygiene monitoring
    • Easicult
    • Hygicult
    • Orion Clean Card PRO
  • RIA / Collagens
    • UniQ
      • UniQ RIA
  • Products available in the USA
Logo
Close
  • Products
    • COVID-19
      • COVID-19 tests
        • Biosynex Covid-19 Ag BSS Rapid Test
    • Point of care
      • QuikRead go
        • QuikRead go Instrument
        • QuikRead go easy CRP
        • QuikRead go CRP
        • QuikRead go CRP+Hb
        • QuikRead go wrCRP
        • QuikRead go wrCRP+Hb
        • QuikRead go HbA1c
        • QuikRead go Strep A
        • QuikRead go iFOBT
        • QuikRead go accessories
      • QuikRead
        • QuikRead 101 Instrument
        • QuikRead CRP
        • QuikRead FOB quantitative
        • QuikRead U-ALB
        • QuikRead 101 accessories
    • Microbiology
      • Uricult
      • Uricult Vet
      • Cultura M
    • Molecular Diagnostics
      • SIBA
    • Hygiene monitoring
      • Easicult
      • Hygicult
      • Orion Clean Card PRO
    • RIA / Collagens
      • UniQ
        • UniQ RIA
    • Products available in the USA
  • About us
  • News
  • Contact
  • Careers
Log in

Suggested topics

antibiotic resistance CRP point-of-care

Popular products

Biosynex Covid-19 Ag BSS Rapid Test

Biosynex Covid-19 Ag BSS Rapid Test

QuikRead go HbA1c

QuikRead go HbA1c

SIBA

SIBA

Latest news

View all

Aidian Oy acquires Mediphos Medical Supplies B.V. and Mediphos Diagnostics Belux B.V.

23 February 2021

CRP levels are strongly associated to clinical outcome of hospitalized patients with COVID-19, irrespective of age, sex, race, or obesity

16 February 2021

QuikRead go iFOBT, proven suitability for Point-of-Care

4 February 2021

  • View all
  • No results found
  • Loading...

News

Aidian Oy acquires Mediphos Medical Supplies B.V. and Mediphos Diagnostics Belux B.V.

23 February 2021

CRP levels are strongly associated to clinical outcome of hospitalized patients with COVID-19, irrespective of age, sex, race, or obesity

16 February 2021

Back to all news
7 December 2018
News

Changes in Orion Diagnostica Oy´s management

Orion Diagnostica Oy announced this morning that Kaisa Tarkkanen will step down as CEO effective December 7th, 2018. Orion Diagnostica's CFO, Antti Koivula, will at the same time be appointed Interim CEO.

Kaisa Tarkkanen has held various management positions within Orion Corporation since 2000. She was appointed CEO of Orion Diagnostica in 2015. In April 2018, Axcel acquired Orion Diagnostica from Orion Corporation and since then Kaisa has successfully been leading the transition of Orion Diagnostica into a stand-alone company. The transition is coming to an end and the Board of Directors of Orion Diagnostica and Kaisa have agreed that it is now time for Kaisa to move on to other challenges. Rolf Classon, Chairman of the Board of Orion Diagnostica, commented, “It has been a pleasure to work with Kaisa and her energy and experience has been very valuable during the transition period. The Board is grateful for Kaisa’s leadership during this time and wishes her good luck in her next career step”.

Antti Koivula is an experienced executive who has had numerous senior roles in companies such as Vapo, Rudus, Prysmian Finland and Metsä Group. In addition to being CFO, Antti will now assume the position of Interim CEO until a permanent new CEO is in place. Antti has in a very short period of time established himself as a strong leader in Orion Diagnostica's executive team and the Board is grateful that he is now prepared to take on even greater responsibilities.

Headquartered in Espoo, Finland, Orion Diagnostica is a leading Point-of-Care diagnostics company. With some 300 employees, Orion Diagnostica develops, manufactures and markets a range of reliable and easy to use instruments and tests. Through its sales force and high quality distributor network, Orion Diagnostica delivers its innovative product range to healthcare practitioners in some 60 countries worldwide.

Axcel is a leading Nordic private equity firm in the mid-cap market with a focus on investing in strong Nordic market leaders. Since its inception nearly 25 years ago, Axcel has invested in well over 50 Nordic companies as well as consummated over 100 add-on acquisitions in the Nordic region and beyond.

Orion Diagnostica Oy

Board of Directors

For further questions, please contact

Antti Koivula, Interim CEO Orion Diagnostica, at +358 50 570 5589

or

Thomas Blomqvist, Partner Axcel, at +46 709 22 10 49

Share
Facebook
Twitter
Email

Aidian Oy

Koivu-Mankkaan tie 6 B,
FI-02200 Espoo,
Finland

P.O. Box 83,
FI-02101 Espoo,
Finland

+358 10 309 3000

Invoicing addresses

E-invoice
Basware 003718552161

Invoicing address
Aidian Oy,
P.O. Box 33,
FI-02101 Espoo,
Finland

Business ID FI18552161

  • Contact
    • Contact in your country
    • Sales related inquiries
  • Careers
  • Privacy
    • Privacy Policy
    • Privacy Statements
    • Cookie Policy
    • Social Media Policy
    • Unsubscribe
  • Products
    • QuikRead go
    • QuikRead
    • Easicult
    • Hygicult
    • Orion Clean Card PRO
    • Uricult
    • Uricult Vet
    • Cultura M
    • UniQ
    • SIBA
    • COVID-19 tests
Copyright © 2021 Aidian

This website uses cookies

We use cookies to personalize content and ads, and to analyze our traffic and improve our service.

Manage Preferences

Necessary (Required)

Cookies that the site cannot function properly without. This includes cookies for access to secure areas and CSRF security. Please note that Craft’s default cookies do not collect any personal or sensitive information. Craft's default cookies do not collect IP addresses. The information they store is not sent to Pixel & Tonic or any 3rd parties.
— CraftSessionId
Provider: this site
Expiration: Session
Description: Craft relies on PHP sessions to maintain sessions across web requests. That is done via the PHP session cookie. Craft names that cookie “CraftSessionId” by default, but it can be renamed via the phpSessionId config setting. This cookie will expire as soon as the session expires.
— *_identity
Provider: this site
Expiration: Persistent
Description: When you log into the Control Panel, you will get an authentication cookie used to maintain your authenticated state. The cookie name is prefixed with a long, randomly generated string, followed by _identity. The cookie only stores information necessary to maintain a secure, authenticated session and will only exist for as long as the user is authenticated in Craft.
— *_username
Provider: this site
Expiration: Persistent
Description: If you check the "Keep me logged in" option during login, this cookie is used to remember the username for your next authentication.
— CRAFT_CSRF_TOKEN
Provider: this site
Expiration: Session
Description: Protects us and you as a user against Cross-Site Request Forgery attacks.

Statistics

Statistic cookies help us understand how visitors interact with websites by collecting and reporting information anonymously.
— _ga
Provider: Google
Expiration: 2 years
Description: Visitor identification
— _gid
Provider: Google
Expiration: 24 hours
Description: User journey
— _gat_UA-*
Provider: Google
Expiration: 10 minutes
Description: Throttling request rate

Marketing

Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Hide Details